| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |